Equities
Health CareHealth Care Equipment & Services
  • Price (USD)101.57
  • Today's Change0.08 / 0.08%
  • Shares traded579.37k
  • 1 Year change9.26%
  • Beta0.6357
Data delayed at least 15 minutes, as of Jan 18 2018 21:01 GMT.
More ▼

Events & Activity

  • DGX:NYQ price rises above 200-day moving average to 102.10 at 09:47 GMT
  • On date 29 Nov 2017, DGX:NYQ announced a new dividend of amount 0.45 payable on date 29 Nov 2017

Key statistics

On Thursday, Quest Diagnostics Inc (DGX:NYQ) closed at 101.57, -10.09% below its 52-week high of 112.97, set on Jul 03, 2017.
52-week range
Today
90.10Oct 19 2017112.97Jul 03 2017
Markit short selling activity
Low
Med
High
Open101.49
High102.09
Low101.11
Bid92.50
Offer105.25
Previous close101.57
Average volume777.44k
Shares outstanding136.30m
Free float135.72m
P/E (TTM)21.16
Market cap13.84bn USD
EPS (TTM)4.80
USD
Annual div (ADY)1.80
USD
Annual div yield (ADY)1.77%
Div ex-dateJan 08 2018
Div pay-dateJan 24 2018
Data delayed at least 15 minutes, as of Jan 18 2018 21:01 GMT.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.